Literature DB >> 22694731

Diagnosis of arteriovenous fistula dysfunction.

Tushar J Vachharajani1.   

Abstract

Arteriovenous fistula (AVF) dysfunction remains a major contributor to the morbidity and mortality of hemodialysis patients. The failure of a newly created AVF to mature and development of stenosis in an established AVF are two common clinical predicaments. The goal is to identify a dysfunctional AVF early enough to intervene in a timely manner to either assist with the maturation process or to prevent thrombosis. The currently available tools in our armamentarium include clinical evaluation, physical examination of the AVF, and surveillance tests. Physical examination has been recognized as a simple and cost-effective tool, but is often not implemented either because of lack of training or time constraints. Surveillance tests include measurement of access flow or pressure as a surrogate marker of AVF dysfunction. Surveillance tests often require expensive equipment, additional personnel, and are controversial. Currently, there are guidelines and recommendations to include all of these measures while evaluating an AVF. Implementing judicious use of these tools in clinical practice can facilitate early diagnosis for timely intervention in the appropriate population. Furthermore, this strategy may avoid unnecessary interventions and assist with healthcare cost containment. Published 2011. This article is a U.S. Government work and it is in the public domain in the USA.

Entities:  

Mesh:

Year:  2012        PMID: 22694731     DOI: 10.1111/j.1525-139X.2012.01094.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  5 in total

Review 1.  Combined functional and anatomical diagnostic endpoints for assessing arteriovenous fistula dysfunction.

Authors:  Ehsan Rajabi-Jaghargh; Rupak K Banerjee
Journal:  World J Nephrol       Date:  2015-02-06

2.  Relationship of late arteriovenous fistula stenosis with soluble E-selectin and soluble EPCR in chronic hemodialysis patients with arteriovenous fistula.

Authors:  Mukadder Ayse Bilgic; Hakki Yilmaz; Alper Bozkurt; Huseyin Tugrul Celik; Ismail Celal Bilgic; Ozgul Malcok Gurel; Ismail Kirbas; Nuket Bavbek; Ali Akcay
Journal:  Clin Exp Nephrol       Date:  2014-03-14       Impact factor: 2.801

3.  Arteriovenous Vascular Access Selection and Evaluation.

Authors:  Jennifer M MacRae; Matthew Oliver; Edward Clark; Christine Dipchand; Swapnil Hiremath; Joanne Kappel; Mercedeh Kiaii; Charmaine Lok; Rick Luscombe; Lisa M Miller; Louise Moist
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

4.  Evaluation of arteriovenous fistula-bilateral computed tomography venography combining diluted and undiluted contrast media injection: A case study.

Authors:  Svensson Anders Rt; Katharina Brehmer; Brismar B Torkel
Journal:  Radiol Case Rep       Date:  2019-11-11

5.  Effects of Tongmai oral liquid in femoral ateriovenous fistula.

Authors:  Pei-Ling Su; Kun Bao; Han-Guo Peng; Wei Mao; Guan-Su Wang; Ni-Zhi Yang; Wen-Jia Geng; Yi-Qun Lin; Xi-Na Jie
Journal:  BMC Complement Altern Med       Date:  2015-09-07       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.